CTOs on the Move

EyePromise

www.eyepromise.com

 
EyePromise provides nutraceuticals, technology and support to enhance and protect vision for people who depend on sight to perform at a higher level, those who face degenerative eye conditions and everyone who wants to see their best every day. With expertise in eye health and nutrition science, EyePromise delivers unmatched products and services. Our extensive line of ocular nutraceuticals covers a full range of patient needs, including macular health at every age, occasional dry eye, blood vessel integrity and athletic visual performance. The EyePromise portfolio also includes the QuantifEye MPS II, the industry-standard macular pigment optical density measurement instrument, to help more ...
  • Number of Employees: 100-250
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

HIP HOP PROMOTIONS

HIP HOP PROMOTIONS is a Van Nuys, CA-based company in the Business Services sector.

Discover-e

Discover-e is one of the leading providers in Business Services. It is based in Portland, OR. To find more information about Discover-e, please visit www.discover-e-legal.com.

Governor of California

Official Twitter of the Office of the Governor of California. #CaliforniaForAll

Twin Cities Public Television

Twin Cities Public Television is a Saint Paul, MN-based company in the Business Services sector.

Climb Bio

Climb Bio, Inc. is a clinical-stage biotechnology company based in Wellesley Hills, Massachusetts. Founded in 2018 and formerly known as Eliem Therapeutics, Climb Bio focuses on developing innovative therapies for immune-mediated diseases. The company emphasizes building strong relationships to gain insights and create effective medicines aimed at improving the quality of life for patients. Climb Bios product pipeline includes Budoprutug, an anti-CD19 monoclonal antibody in various stages of development for B-cell mediated diseases, and CLYM116, an anti-APRIL monoclonal antibody in preclinical development for IgA Nephropathy. The company is committed to advancing life sciences through innovative research and clinical trials, with a dedicated team led by CEO Aoife Brennan.